Cargando…

A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data

The goal of this study is to summarize valvular surgery data from the Chinese Cardiac Surgery Registry (CCSR) and compare it to the most recent data from the Society of Thoracic Surgeons (STS). From 2016 to 2018, a total of 34,386 cases of the seven most common valvular surgical procedures was obtai...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hongyuan, Gong, Jiamiao, Wu, Yongjian, Zheng, Zhe, Hou, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319982/
https://www.ncbi.nlm.nih.gov/pubmed/35877574
http://dx.doi.org/10.3390/jcdd9070212
_version_ 1784755682647474176
author Lin, Hongyuan
Gong, Jiamiao
Wu, Yongjian
Zheng, Zhe
Hou, Jianfeng
author_facet Lin, Hongyuan
Gong, Jiamiao
Wu, Yongjian
Zheng, Zhe
Hou, Jianfeng
author_sort Lin, Hongyuan
collection PubMed
description The goal of this study is to summarize valvular surgery data from the Chinese Cardiac Surgery Registry (CCSR) and compare it to the most recent data from the Society of Thoracic Surgeons (STS). From 2016 to 2018, a total of 34,386 cases of the seven most common valvular surgical procedures was obtained from the CCSR. We calculated the proportions of different procedures in the CCSR cohort (n = 34,386) as well as the change in operation volume for each procedure. We also compiled rates of postoperative in-hospital mortality and five major complications across all procedures. All of the results were compared to the STS data. The CCSR and STS data showed divergent trends in valvular heart disease features and operation volume. Although the proportion of MV repair in the CCSR (13.7%) data was lower than in the STS data (23.2%), it demonstrated a substantial upward trend. In terms of operation volume, the CCSR data showed an upward trend, but the STS data showed a downward trend. CCSR procedures showed lower mortality (2% vs. 2.6%), reoperation (2.8% vs. 4.3%), and permanent stroke (0.5% vs. 1.6%) rates than STS procedures but higher rates of prolonged ventilation (22.4% vs. 10.4%) and renal failure (5.6% vs. 3.2%). Valvular surgery quality in China’s leading cardiac hospitals is roughly comparable to that in the United States. China, on the other hand, has some shortcomings that need improvement.
format Online
Article
Text
id pubmed-9319982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93199822022-07-27 A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data Lin, Hongyuan Gong, Jiamiao Wu, Yongjian Zheng, Zhe Hou, Jianfeng J Cardiovasc Dev Dis Article The goal of this study is to summarize valvular surgery data from the Chinese Cardiac Surgery Registry (CCSR) and compare it to the most recent data from the Society of Thoracic Surgeons (STS). From 2016 to 2018, a total of 34,386 cases of the seven most common valvular surgical procedures was obtained from the CCSR. We calculated the proportions of different procedures in the CCSR cohort (n = 34,386) as well as the change in operation volume for each procedure. We also compiled rates of postoperative in-hospital mortality and five major complications across all procedures. All of the results were compared to the STS data. The CCSR and STS data showed divergent trends in valvular heart disease features and operation volume. Although the proportion of MV repair in the CCSR (13.7%) data was lower than in the STS data (23.2%), it demonstrated a substantial upward trend. In terms of operation volume, the CCSR data showed an upward trend, but the STS data showed a downward trend. CCSR procedures showed lower mortality (2% vs. 2.6%), reoperation (2.8% vs. 4.3%), and permanent stroke (0.5% vs. 1.6%) rates than STS procedures but higher rates of prolonged ventilation (22.4% vs. 10.4%) and renal failure (5.6% vs. 3.2%). Valvular surgery quality in China’s leading cardiac hospitals is roughly comparable to that in the United States. China, on the other hand, has some shortcomings that need improvement. MDPI 2022-07-02 /pmc/articles/PMC9319982/ /pubmed/35877574 http://dx.doi.org/10.3390/jcdd9070212 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lin, Hongyuan
Gong, Jiamiao
Wu, Yongjian
Zheng, Zhe
Hou, Jianfeng
A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data
title A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data
title_full A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data
title_fullStr A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data
title_full_unstemmed A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data
title_short A Comparative Study on Surgical Treatment of Valvular Heart Disease between High-Volume Cardiac Centers in China and STS Data
title_sort comparative study on surgical treatment of valvular heart disease between high-volume cardiac centers in china and sts data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319982/
https://www.ncbi.nlm.nih.gov/pubmed/35877574
http://dx.doi.org/10.3390/jcdd9070212
work_keys_str_mv AT linhongyuan acomparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT gongjiamiao acomparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT wuyongjian acomparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT zhengzhe acomparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT houjianfeng acomparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT linhongyuan comparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT gongjiamiao comparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT wuyongjian comparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT zhengzhe comparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata
AT houjianfeng comparativestudyonsurgicaltreatmentofvalvularheartdiseasebetweenhighvolumecardiaccentersinchinaandstsdata